explore -WSS

explore

author：focus 2025-09-30 21:57:47 - browse：258

Photo of an arrangement of aspirin pills — Patrick Sison/AP

Low-dose aspirin led to a reduction in liver fat among patients with metabolic-associated liver disease, a small study out of Boston found.

The clinical trial, led by Tracey Simon of Massachusetts General Hospital and Harvard Medical School, compared two groups of patients with metabolic dysfunction-associated steatotic liver disease, or MASLD. One group was given baby aspirin daily for six months, while the other received a placebo pill. At the end of the study period, the aspirin group had reduced hepatic fat content while the placebo group had higher fat buildup.

MASLD (formerly known as non-alcoholic fatty liver disease) is a growing health threat, with 1 in 3 Americans having a troublesome amount of fat in their liver. The lipid buildup feeds into a toxic cycle of inflammation, tissue damage and, ultimately, irreversible scarring.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Fentanyl is making it harder to start addiction treatment

leisure time

WSS

Citing H5N1 threat, CDC urges peak flu monitoring this summer

HHS names first

Risky weight loss products often used by teens globally, per study

GSK to buy asthma

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

ASCO eve: Let’s set the table for this year's meeting

hotspot

explore

Wikipedia

Duchenne breakthrough therapy leaves behind pioneering families

Investigation reveals sickle cell patients pressured into sterilizations

Walensky prepares to leave CDC — and Congress — behind

Digital health: a case of mistaken identity

After affirmative action ruling, medical educators look to 'holistic review'

H5N1 bird flu outbreak: Second human case reported, in Michigan

Affirmative action in medical school literally saved lives

New Medicare drug pricing powers could soon be upended in court

Guidelines to prevent youth baseball injuries need more muscle

Scrutiny of post

Wikipedia

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

Risky weight loss products often used by teens globally, per study

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

H5N1 virus can be tracked in retail milk, scientists say

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

explore

focus

leisure time

Wikipedia